Anthem, Inc. Stock: price and management transactions · United States · SEC (Form 4)

About Anthem, Inc.

Anthem, Inc. is now known as Elevance Health, Inc., following the 2022 corporate name change, but the Anthem name still appears frequently in historical filings, legacy market references, and many investor databases. For market context, the company is a U.S.-listed healthcare group on the NYSE: it previously traded under ANTM and now trades under ELV. For French, Belgian, and Swiss investors, the business is best understood as a large managed-care and health benefits platform rather than a pure-play insurer. Elevance Health is incorporated in Indiana and is headquartered in Indianapolis, Indiana, in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1156039/000115603923000007/elv-20221231.htm?utm_source=openai)) The company’s roots date back to 1944, when it was formed as Mutual Hospital Insurance, Inc., commonly known as Blue Cross of Indiana. Over time, Anthem expanded through a combination of organic growth and acquisitions, building a broad footprint across U.S. health benefits markets. SEC disclosures show that in 2021 the company served more than 45 million medical members and offered a wide spectrum of network-based managed care products across the Individual, Group, Medicaid, and Medicare segments. In addition, it provided fee-based managed-care services such as claims processing, stop-loss insurance, provider network access, medical management, care management, wellness programs, actuarial services, and other administrative solutions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1156039/000091205702024240/a2081972zs-1.htm?utm_source=openai)) From a competitive standpoint, Anthem established itself as one of the largest health benefits companies in the United States by medical membership, with especially strong positions in Blue Cross Blue Shield-affiliated plans, employer-sponsored coverage, and government programs. The group’s current brand architecture includes Anthem Blue Cross and Blue Shield, Carelon, and Wellpoint, reflecting a broader strategy that combines insurance with healthcare services, pharmacy, behavioral health, complex care, and data-driven insights. This integrated model is designed to improve cost discipline, member experience, and care coordination across the healthcare value chain. ([elevancehealth.com](https://www.elevancehealth.com/who-we-are/companies?utm_source=openai)) Its core offering now spans health plans, provider networks, pharmacy-related services, behavioral health, Medicaid and Medicare solutions, and a range of clinical and administrative services for both individuals and employer groups. Geographically, the business remains primarily focused on the United States, with a multi-state operating model rather than a globally diversified footprint. Recent developments include 2026 organizational changes aimed at strengthening execution and supporting growth, alongside continuing exposure to healthcare cost inflation, regulatory pressure, public-program reimbursement dynamics, and medical utilization trends. For equity investors, the name change did not alter the underlying profile: this remains a large, defensive U.S. healthcare franchise with recurring revenue characteristics, but one that is highly sensitive to regulation, pricing discipline, and the economics of managed care. ([elevancehealth.com](https://www.elevancehealth.com/newsroom/elevance-health-announces-leadership-appointments-to-strengthen-execution-and-drive-growth?utm_source=openai))